Viewing Study NCT06908993


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2025-12-27 @ 3:46 AM
Study NCT ID: NCT06908993
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module